GeoVax Labs Profit Margin 2006-2021 | GOVX
Current and historical gross margin, operating margin and net profit margin for GeoVax Labs (GOVX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. GeoVax Labs net profit margin as of September 30, 2021 is -1305.93%.
|GeoVax Labs Annual Profit Margins
|GeoVax Labs Quarterly Profit Margins
||Medical - Biomedical and Genetics
GeoVax Labs Inc. is a clinical-stage biotechnology company. It engages in developing human vaccines against infectious diseases and cancer using a novel patented Modified Vaccinia Ankara-Virus Like Particle based vaccine platform. GeoVax Labs Inc. is based in ATLANTA, GA.